Diary - News   All news EU Lead Factory and CELLIPSE achieve 1st Collaboration Milestone

EU Lead Factory and CELLIPSE achieve 1st Collaboration Milestone

European Lead Factory (ELF) and CELLIPSE announced today completion of the 1st phase of their collaboration program to identify hits against an undisclosed innovative therapeutic target that is involved in cytoskeleton regulation.

The qualified hit list delivered to CELLIPSE was obtained from a screening program on ELF’s Joint European Chemical Library that included more than 400,000 (now 450,000) compounds.

Read the press release

Contact

Bâtiment EKLAA - 63 avenue Tony Garnier, 69007 Lyon

Tel. : 04.72.76.53.30 - Fax : 09.55.91.30.26

info@lyonbiopole.com